Pfizer dumps a hemophilia pact with Catalyst, threatening its Targacept merger - FierceBiotech

http://ift.tt/1aNAUOT Click to read full article...

Pfizer dumps a hemophilia pact with Catalyst, threatening its Targacept mergerFierceBiotechSix years after Catalyst Biosciences inked a $500 million-plus deal to develop a Factor VIIa therapies for hemophilia, Pfizer is walking away from the pact it inherited from Wyeth. And now Targacept, which just struck a reverse merger pact to get ...

from Hemophilia - Google News http://ift.tt/1aNAUOT via IFTTT